125 related articles for article (PubMed ID: 25462566)
21. Development of Herceptin resistance in breast cancer cells.
Kute T; Lack CM; Willingham M; Bishwokama B; Williams H; Barrett K; Mitchell T; Vaughn JP
Cytometry A; 2004 Feb; 57(2):86-93. PubMed ID: 14750129
[TBL] [Abstract][Full Text] [Related]
22. IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death.
Tezil T; Bodur C; Kutuk O; Basaga H
Cell Signal; 2012 Jun; 24(6):1361-8. PubMed ID: 22313691
[TBL] [Abstract][Full Text] [Related]
23. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
24. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
25. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.
Lian WJ; Liu G; Liu YJ; Zhao ZW; Yi T; Zhou HY
Oncol Rep; 2013 Jul; 30(1):193-200. PubMed ID: 23674072
[TBL] [Abstract][Full Text] [Related]
27. Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression.
Wang L; Wang G; Yang D; Guo X; Xu Y; Feng B; Kang J
Mol Med Rep; 2013 Oct; 8(4):1279-85. PubMed ID: 23969579
[TBL] [Abstract][Full Text] [Related]
28. Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells.
Xu JW; Li QQ; Tao LL; Cheng YY; Yu J; Chen Q; Liu XP; Xu ZD
Int J Oncol; 2011 Dec; 39(6):1501-9. PubMed ID: 21805028
[TBL] [Abstract][Full Text] [Related]
29. Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells.
Gao YF; Zhu T; Mao XY; Mao CX; Li L; Yin JY; Zhou HH; Liu ZQ
Oncol Rep; 2017 Feb; 37(2):1196-1202. PubMed ID: 28075458
[TBL] [Abstract][Full Text] [Related]
30. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.
Zou L; Ding Z; Roy P
J Cell Physiol; 2010 Jun; 223(3):623-9. PubMed ID: 20143334
[TBL] [Abstract][Full Text] [Related]
31. Effect of p27 on motility of MDA-MB-231 breast cancer cells.
Lee EY; Jeon MJ; Yang W; Shin I
Oncol Rep; 2009 Jun; 21(6):1621-5. PubMed ID: 19424645
[TBL] [Abstract][Full Text] [Related]
32. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis.
Cai K; Chen S; Zhu C; Li L; Yu C; He Z; Sun C
Cell Death Dis; 2022 Sep; 13(9):765. PubMed ID: 36057597
[TBL] [Abstract][Full Text] [Related]
33. Correlations between forkhead box D1 expression and clinicopathological characteristics of patients with bladder cancer and influence on biological behaviors of bladder cancer cells.
Wang F; Yang J
Arch Esp Urol; 2022 Apr; 75(3):274-281. PubMed ID: 35435161
[TBL] [Abstract][Full Text] [Related]
34. Pttg1 Promotes Growth of Breast Cancer through P27 Nuclear Exclusion.
Xiea Y; Wangb R
Cell Physiol Biochem; 2016; 38(1):393-400. PubMed ID: 26824458
[TBL] [Abstract][Full Text] [Related]
35. Foxd1 is a mediator and indicator of the cell reprogramming process.
Koga M; Matsuda M; Kawamura T; Sogo T; Shigeno A; Nishida E; Ebisuya M
Nat Commun; 2014; 5():3197. PubMed ID: 24496101
[TBL] [Abstract][Full Text] [Related]
36. The multisystemic functions of FOXD1 in development and disease.
Quintero-Ronderos P; Laissue P
J Mol Med (Berl); 2018 Aug; 96(8):725-739. PubMed ID: 29959475
[TBL] [Abstract][Full Text] [Related]
37. miR-30e-5p-mediated FOXD1 promotes cell proliferation by blocking cellular senescence and apoptosis through p21/CDK2/Rb signaling in head and neck carcinoma.
Wu T; Yang Z; Chen W; Jiang M; Xiao Z; Su X; Jiao Z; Yu Y; Chen S; Song M; Yang A
Cell Death Discov; 2023 Aug; 9(1):295. PubMed ID: 37563111
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility.
Wang S; Jiang Y; Liu J; Zhao Y; Xiang C; Ma R; Gao H; Jin L; He F; Wang H
Tumour Biol; 2014 Aug; 35(8):8289-99. PubMed ID: 24852432
[TBL] [Abstract][Full Text] [Related]
39. Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers.
Cheng L; Yan H; Liu Y; Guan G; Cheng P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188986. PubMed ID: 37716516
[TBL] [Abstract][Full Text] [Related]
40. Endothelial Progenitors Exist within the Kidney and Lung Mesenchyme.
Sims-Lucas S; Schaefer C; Bushnell D; Ho J; Logar A; Prochownik E; Gittes G; Bates CM
PLoS One; 2013; 8(6):e65993. PubMed ID: 23823180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
